Literature DB >> 22056958

Orexinergic neuron numbers in three species of African mole rats with rhythmic and arrhythmic chronotypes.

A Bhagwandin1, N Gravett, J Hemingway, M K Oosthuizen, N C Bennett, J M Siegel, P R Manger.   

Abstract

In the present study, orexinergic cell bodies within the brains of rhythmic and arrhythmic circadian chronotypes from three species of African mole rat (Highveld mole rat-Cryptomys hottentotus pretoriae, Ansell's mole rat--Fukomys anselli and the Damaraland mole rat--Fukomys damarensis) were identified using immunohistochemistry for orexin-A. Immunopositive orexinergic (Orx+) cell bodies were stereologically assessed and absolute numbers of orexinergic cell bodies were determined for the distinct circadian chronotypes of each species of mole rat examined. The aim of the study was to investigate whether the absolute numbers of identified orexinergic neurons differs between distinct circadian chronotypes with the hypothesis of elevated hypothalamic orexinergic neurons in the arrhythmic chronotypes compared with the rhythmic chronotypes. We found statistically significant differences between the circadian chronotypes ofF. anselli, where the arrhythmic group had higher mean numbers of hypothalamic orexin neurons compared with the rhythmic group. These differences were observed when the raw data was compared and when the raw data was corrected for body mass (M(b)) and brain mass (M(br)). For the two other species investigated, no significant differences were noted between the chronotypes, although a statistically significant difference was noted between all rhythmic and arrhythmic individuals of the current study when the counts of orexin neurons were corrected for M(b)--the arrhythmic individuals had larger numbers of orexin cells.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056958      PMCID: PMC8762454          DOI: 10.1016/j.neuroscience.2011.10.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  51 in total

1.  Sleep and wake in rhythmic versus arrhythmic chronotypes of a microphthalmic species of African mole rat (Fukomys mechowii).

Authors:  Adhil Bhagwandin; Nadine Gravett; Oleg I Lyamin; Maria K Oosthuizen; Nigel C Bennett; Jerome M Siegel; Paul R Manger
Journal:  Brain Behav Evol       Date:  2011-09-26       Impact factor: 1.808

2.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

Authors:  L Lin; J Faraco; R Li; H Kadotani; W Rogers; X Lin; X Qiu; P J de Jong; S Nishino; E Mignot
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

3.  The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin.

Authors:  C M Edwards; S Abusnana; D Sunter; K G Murphy; M A Ghatei; S R Bloom
Journal:  J Endocrinol       Date:  1999-03       Impact factor: 4.286

4.  Energetics in a solitary subterranean rodent, the silvery mole-rat, Heliophobius argenteocinereus, and allometry of RMR in African mole-rats (Bathyergidae).

Authors:  Jitka Zelová; Radim Sumbera; Frantisek Sedlácek; Hynek Burda
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2007-01-23       Impact factor: 2.320

5.  Visual system labeled by c-Fos immunohistochemistry after light exposure in the 'blind' subterranean zambian mole-rat (Cryptomys anselli).

Authors:  H H Oelschläger; M Nakamura; M Herzog; H Burda
Journal:  Brain Behav Evol       Date:  2000-04       Impact factor: 1.808

6.  Independent feeding and metabolic actions of orexins in mice.

Authors:  M Lubkin; A Stricker-Krongrad
Journal:  Biochem Biophys Res Commun       Date:  1998-12-18       Impact factor: 3.575

Review 7.  The visual system in subterranean African mole-rats (Rodentia, Bathyergidae): retina, subcortical visual nuclei and primary visual cortex.

Authors:  Pavel Nemec; Pavla Cveková; Oldrich Benada; Ewa Wielkopolska; Seweryn Olkowicz; Kris Turlejski; Hynek Burda; Nigel C Bennett; Leo Peichl
Journal:  Brain Res Bull       Date:  2007-11-26       Impact factor: 4.077

8.  Cortical activity and sleep in the rat lateral hypothalamic syndrome.

Authors:  J Danguir; S Nicolaidis
Journal:  Brain Res       Date:  1980-03-10       Impact factor: 3.252

Review 9.  Hypocretin (orexin): role in normal behavior and neuropathology.

Authors:  Jerome M Siegel
Journal:  Annu Rev Psychol       Date:  2004       Impact factor: 24.137

10.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

View more
  4 in total

1.  Organization and number of orexinergic neurons in the hypothalamus of two species of Cetartiodactyla: a comparison of giraffe (Giraffa camelopardalis) and harbour porpoise (Phocoena phocoena).

Authors:  Leigh-Anne Dell; Nina Patzke; Adhil Bhagwandin; Faiza Bux; Kjell Fuxe; Grace Barber; Jerome M Siegel; Paul R Manger
Journal:  J Chem Neuroanat       Date:  2012-06-08       Impact factor: 3.052

2.  Orexinergic bouton density is lower in the cerebral cortex of cetaceans compared to artiodactyls.

Authors:  Leigh-Anne Dell; Muhammad A Spocter; Nina Patzke; Karl Æ Karlson; Abdulaziz N Alagaili; Nigel C Bennett; Osama B Muhammed; Mads F Bertelsen; Jerome M Siegel; Paul R Manger
Journal:  J Chem Neuroanat       Date:  2015-07-30       Impact factor: 3.052

3.  Neural Damage in Experimental Trypanosoma brucei gambiense Infection: Hypothalamic Peptidergic Sleep and Wake-Regulatory Neurons.

Authors:  Claudia Laperchia; Yuan-Zhong Xu; Dieudonné Mumba Ngoyi; Tiziana Cotrufo; Marina Bentivoglio
Journal:  Front Neuroanat       Date:  2018-02-27       Impact factor: 3.856

Review 4.  An overview of the orexinergic system in different animal species.

Authors:  Idris A Azeez; Olumayowa O Igado; James O Olopade
Journal:  Metab Brain Dis       Date:  2021-07-05       Impact factor: 3.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.